Medbroadcast – Powered by MediResource
 Search

Go
 Browse alphabetically
ABCDEFGHIJKLMN
OPQRSTUVWXYZ
HEALTH TOPICS
Family & Child Health
Men's Health
Women's Health
Seniors' Health
Addiction
Allergy
Ankylosing Spondylitis
Arthritis (Rheumatoid)
Asthma
Baby Health
Back Health
Bedwetting
Bladder (Overactive)
Brain Health
Cancer
Cholesterol
Cold and Flu
Crohn's & Colitis
Cosmetic Procedures
Depression
Diabetes
Digestive Health
Ear Health
Eating Disorders
Eye Health
Flu (Seasonal) NEW!
Fertility
Fitness
H1N1 (Swine Flu)
Healthcare in Canada
Healthy Skin
Heart
High Blood Pressure
Hormone
HPV
Infection
Kidney Health
Lung Health
Menopause
Menstruation
Mental Health
Multiple Sclerosis
Natural and Complementary Therapy
Nutrition
Obesity
Oral Care
Pain
Pregnancy
Psoriasis
Psoriatic Arthritis (PsA)
Seasonal Health
Sexual Health
Sleep Health
Smoking
Weight Management
Workplace Health
Yeast Infection
All health channels

STAY CONNECTED
RESOURCES
Ask an Expert
Clinical Trials
Community Forum
Find a Specialist
Health features
Human Atlas Videos
News
Tools


Condition Info Drug Info Tests and Procedures Natural Products Ask an Expert Support Groups Clinical Trials
Health eTalk Forums: Share your experiences with the Medbroadcast community! Health eTalk Forums
Home Bookmark Page Send to a Friend Sante Chez Nous Subscribe
HPV > Health News > GSK says still no answer on whether H1N1 vaccine batch triggers more reaction
HPV
Info for Young Women
Info for Mothers
HPV resources
Health features
Health tools
Expert answers
Support groups
Related conditions
Advertisement

GSK says still no answer on whether H1N1 vaccine batch triggers more reaction

Nov. 24, 2009Get Medbroadcast Health News via RSS Feed


Provided by: The Canadian Press
Written by: Helen Branswell, Medical Reporter, THE CANADIAN PRESS

TORONTO - The investigation into whether a batch of H1N1 vaccine may have triggered a higher-than-normal rate of allergic reactions hasn't yet come up with answers, vaccine manufacturer GlaxoSmithKline said Tuesday.

And health officials in Quebec said they are still trying to determine if the death of an elderly man who died of anaphylaxis after receiving a pandemic flu shot was triggered or hastened by the vaccination.

"Investigations being undertaken by GSK, Health Canada and the Public Health Agency of Canada (PHAC) have not yet been completed," GSK spokesperson Megan Spoore said in an email about the pulled batch of vaccine.

The lot, No. A80CA007A, comprised 172,000 doses of vaccine that were shipped last month to British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Prince Edward Island.

Quebec did not receive vaccine from the batch under investigation.

After discussions with Health Canada, which regulates vaccines, GSK told provinces last week not to use any more doses from this lot after it came to light that six cases of anaphylaxis had been reported in people who had H1N1 shots from the batch.

The event is raising a lot of questions. Here are some answers:

Q: What is anaphylaxis?

A: Anaphylaxis is a severe allergic reaction that in extreme cases can lead to death. Marked by sudden onset, the reaction can produce hives, cardiovascular problems and swelling of the tissues in the mouth and airways that can compromise breathing.

True anaphylaxis has to meet an internationally accepted diagnostic criterion called the Brighton collaboration case definition. It must involve at least two organ symptoms - in other words, some combination of reactions involving the skin, heart and respiratory systems.

Q: What causes anaphylaxis?

A: Anaphylaxis is an allergic response to exposure to an allergen, a non-pathogenic (i.e. not a germ or a fungus) substance that's capable of triggering a response from the immune system. For some people, pollen is an allergen. For others, peanut protein is.

Why some people are allergic to some things and others are not isn't clear. But when a person with an allergy encounters the specific allergen, his or her immune system generates a type of antibodies that trigger the release of histamines into their system, says Dr. Scott Halperin, a vaccine expert at Dalhousie University. Histamines induce the response.

Q: How is anaphylaxis treated?

A: True anaphylaxis is treated with epinephrine (adrenaline). That's the stuff in EpiPens carried by people with life-threatening allergies.

Q: Are there any doses of this suspect batch of vaccine left?

A: By the time GSK issued the halt-use order last week, all but about 20,000 doses of the batch had been used, a spokesperson for the Public Health Agency of Canada says.

Q: So that's about six cases of anaphylaxis out of about 152,000 shots given. Is that unduly high?

A: GSK said in a statement Tuesday that the expected rate of anaphylactic reactions to flu shots is in about one in 100,000.

Q: Is anaphylaxis a reaction seen with other vaccines or just flu shots.

A: "Any time you immunize somebody with something, there's always a chance of an allergic reaction," says Dr. John Treanor, an influenza vaccine expert at the University of Rochester in New York.

And if you vaccinate millions? "Some people are going to have anaphylaxis, absolutely," Treanor says.

Halperin says the rate of anaphylactic reactions will vary depending on the type of vaccine used and the age of the people the vaccine is being given to.

It can even vary by location. Australia saw higher than expected rates of anaphylaxis when it rolled out its HPV vaccine campaign - about 2.6 cases per 100,000 shots, according to one study. But those elevated rates weren't seen in North America.

Q: Why do some people have allergic reactions to vaccines?

A: "For most times people have anaphylaxis, you don't know exactly what it is. And vaccine is a complex mixture," Halperin says.

Most flu vaccine - and all the flu vaccine used in Canada - is produced in eggs. If there was residual egg protein in the vaccine it could trigger an allergic response in people with egg allergies, he says.

With the combined measles, mumps and rubella vaccine, reactions have occurred that are believed to be due to an antibiotic that is used in the production process, Halperin says.

Q: Why would one batch of vaccine produce more reactions than others?

A: Treanor says that's a difficult question to answer.

"It's hard for me to think of what the mechanism would be for a lot-specific increase in anaphylactic reactions," he says.

"The only thing that would make sense if it was really true that you were seeing with a specific batch that there were more anaphylactic reactions that there's something in that batch that's not in the other batches . . . that people tend to be allergic to."

Did you find what you were looking for on our website? Please let us know.

Get Medbroadcast Health News via RSS FeedBookmark and Share



Was this article helpful to you? Rate this article on a scale of 1 to 5 (5 = Excellent)

5 - 4 - 3 - 2 - 1

Your feedback helps us to create better, more useful health content.







Hot Topics Ankylosing Spondylitis, Cholesterol, Cold and Flu, Crohn's & Colitis, Digestive Health, Fertility, HPV, Menstruation, Oral Care, Overactive Bladder, Pregnancy, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis


The contents of this site are for informational purposes only and are meant to be discussed with your physician or other qualified health care professional before being acted on. Never disregard any advice given to you by your doctor or other qualified health care professional. Always seek the advice of a physician or other licensed health care professional regarding any questions you have about your medical condition(s) and treatment(s). This site is not a substitute for medical advice.
© 1996 - 2010 MediResource Inc. - MediResource reaches millions of Canadians each year.